Clinical Trials Directory

Trials / Unknown

UnknownNCT03373682

Safety and Efficacy of ESWL for Geriatric Patients With Chronic Pancreatitis

Safety and Efficacy of Extracorporeal Shock Wave Lithotripsy for Geriatric Patients With Chronic Pancreatitis

Status
Unknown
Phase
Study type
Observational
Enrollment
1,404 (actual)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Pancreatic extracorporeal shock wave lithotripsy (P-ESWL) is recommended as the first-line treatment for pancreatic stones. However, how well P-ESWL performs in geriatric patients remains unclear. The investigators aimed to evaluate the safety and efficacy of P-ESWL for geriatric patients with chronic pancreatitis.

Detailed description

This prospective observational study was conducted in patients with painful chronic pancreatitis who underwent P-ESWL. Patients aged over 65 years were included in the geriatric group; patients aged under 65 years who underwent P-ESWL in the same period were assigned to the control group. For investigation of long-term follow-up, the geriatric group were matched with patients from the control group in a 1:1 ratio. The primary outcomes were P-ESWL complications and pain relief. The secondary outcomes included: stone clearance, physical and mental health, quality of life score, and body weight.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2016-04-30
Completion
2018-04-30
First posted
2017-12-14
Last updated
2017-12-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03373682. Inclusion in this directory is not an endorsement.